0001209191-19-017464.txt : 20190306
0001209191-19-017464.hdr.sgml : 20190306
20190306173800
ACCESSION NUMBER: 0001209191-19-017464
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20190227
FILED AS OF DATE: 20190306
DATE AS OF CHANGE: 20190306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Huller Kelly
CENTRAL INDEX KEY: 0001768417
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35621
FILM NUMBER: 19663590
MAIL ADDRESS:
STREET 1: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDOBON
STATE: PA
ZIP: 19403
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GLOBUS MEDICAL INC
CENTRAL INDEX KEY: 0001237831
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043744954
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
BUSINESS PHONE: 610-930-1800
MAIL ADDRESS:
STREET 1: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2019-02-27
0
0001237831
GLOBUS MEDICAL INC
GMED
0001768417
Huller Kelly
VALLEY FORGE BUSINESS CENTER
2560 GENERAL ARMISTEAD AVENUE
AUDUBON
PA
19403
0
1
0
0
SVP, General Counsel
Class A Common Stock
15384
D
Stock Option (Right to Buy Class A Common Stock)
11.86
2020-06-16
Class A Common Stock
3076
D
Stock Option (Right to Buy Class A Common Stock)
11.28
2021-02-11
Class A Common Stock
23076
D
Stock Option (Right to Buy Class A Common Stock)
15.34
2022-08-29
Class A Common Stock
2500
D
Stock Option (Right to Buy Class A Common Stock)
12.59
2023-01-30
Class A Common Stock
7500
D
Stock Option (Right to Buy Class A Common Stock)
24.90
2024-03-04
Class A Common Stock
7500
D
Stock Option (Right to Buy Class A Common Stock)
25.80
2025-04-01
Class A Common Stock
7500
D
Stock Option (Right to Buy Class A Common Stock)
24.21
2026-02-02
Class A Common Stock
7500
D
Stock Option (Right to Buy Class A Common Stock)
25.96
2027-02-02
Class A Common Stock
7500
D
Stock Option (Right to Buy Class A Common Stock)
45.64
2028-02-02
Class A Common Stock
10000
D
Stock Option (Right to Buy Class A Common Stock)
43.58
2029-01-22
Class A Common Stock
40000
D
These options were granted on June 16, 2010 and are fully vested.
These options were granted on February 11, 2011 and are fully vested.
These options were granted on August 29, 2012 and are fully vested.
These options were granted on January 30, 2013 and are fully vested.
These options were granted on March 4, 2014 and are fully vested.
These options were granted on April 1, 2015 and are fully vested.
These options were granted on February 2, 2016, and vest over a four-year period with one-fourth(1/4) of the options granted vesting on January 1, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on February 2, 2017, and vest over a four-year period with one-fourth(1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on February 2, 2018, and vest over a four-year period with one-fourth(1/4) of the options granted vesting on January 1, 2019, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on January 22, 2019, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2020, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
/s/ Kelly G. Huller
2019-03-06
EX-24.3_840493
2
poa.txt
POA DOCUMENT
Know all by these presents that the undersigned hereby constitutes and appoints
Adam M. Cole, acting alone, signing singly, the undersigned's true and lawful
attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the
undersigned's capacity as an officer, director and/or 10% or more stockholder of
Globus Medical, Inc. (the "Company"), Forms ID, 3, 4, 5 and Update Passphrase
Acknowledgement (and any amendments thereto) in accordance with Section 16(a) of
the Securities Exchange Act of 1934, as amended (the "1934 Act"), and the rules
promulgated thereunder; (2) do and perform any and all acts for and on behalf of
the undersigned which may be necessary or desirable to complete and execute any
such Form ID, 3, 4, 5 and Update Passphrase Acknowledgement (and any amendments
thereto) and to file timely such form with the United States Securities and
Exchange Commission and any stock exchange or similar authority; and (3) take
any other action of any type whatsoever in connection with the foregoing which
in the opinion of such attorney-in-fact may be of benefit to, in the best
interest of, or legally required by, the undersigned, it being understood that
the documents executed by such attorney-in-fact on behalf of the undersigned
pursuant to this Power of Attorney shall be in such form and shall contain such
terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to such attorney-in-fact full power and authority
to do and perform any and every act and thing whatsoever requisite, necessary or
proper to be done in the exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the undersigned might or could
do if personally present, with full power of substitution or revocation, hereby
ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this Power of Attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorney-in-fact, in
serving in such capacity at the request of the undersigned, is not assuming, nor
is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the 1934 Act.
This Power of Attorney revokes any and all prior powers of attorney and shall
remain in full force and effect until the undersigned is no longer required to
file Forms ID, 3, 4 and 5 with respect to the undersigned's holdings of and
transactions in securities issued by the Company, unless earlier revoked by the
undersigned in a signed writing delivered to the foregoing attorney-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 5 day of March 2019.
/s/ Kelly G. Huller
Kelly G. Huller